unknown
Stage
About
Basilard BioTech develops Celletto™, a nanomechanical gene delivery platform designed to improve scalability, reduce costs, and increase safety in the manufacturing of cell and gene therapies by offering a non-viral approach to gene delivery.
Explore Basilard BioTech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.